Old Web
English
Sign In
Acemap
>
authorDetail
>
Terrie L Ulery
Terrie L Ulery
Alexion Pharmaceuticals
Pharmacodynamics
Medicine
Nuclear gene
TAF9
Molecular biology
3
Papers
58
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase I study of samalizumab in chronic lymphocytic leukemia and multiple myeloma: blockade of the immune checkpoint CD200.
2019
Journal for ImmunoTherapy of Cancer
Daruka Mahadevan
Mark C. Lanasa
Charles M. Farber
Manjari Pandey
Maria Whelden
Susan J. Faas
Terrie L Ulery
Anjli Kukreja
Lan Li
Camille L. Bedrosian
Xiaoping Zhang
Leonard T. Heffner
Show All
Source
Cite
Save
Citations (36)
First-In-Human Phase I Dose Escalation Study of a Humanized Anti-CD200 Antibody (Samalizumab) In Patients with Advanced Stage B Cell Chronic Lymphocytic Leukemia (B-CLL) or Multiple Myeloma (MM)
2010
Blood
Daruka Mahadevan
Mark C. Lanasa
Maria Whelden
Susan Faas
Terrie L Ulery
Anjli Kukreja
Lan Li
Camille L. Bedrosian
Leonard T. Heffner
Show All
Source
Cite
Save
Citations (17)
XIII. Yeast mapping reports. MTF1, encoding the yeast mitochondrial RNA polymerase specificity factor, is located on chromosome XIII
1994
Yeast
Terrie L Ulery
Judith A. Jaehning
Show All
Source
Cite
Save
Citations (5)
1